Skip to main content

CYCC

Stock
Health Care
Biotechnology

Performance overview

CYCC Price
Price Chart

Forward-looking statistics

Beta
1.13
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

cyclacel limited is a pharmaceuticals company located in 46-48 e smithfield, london, united kingdom.

Company info

SectorHealth Care
IndustryBiotechnology
Employees13
Market cap$2.9M

Fundamentals

Enterprise value$3.9M
Revenue$14.0K
Revenue per employee
Profit margin0.00%
Debt to equity0.29

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)$43.20
Dividend per share
Revenue per share$0.00
Avg trading volume (30 day)$24M
Avg trading volume (10 day)$13M
Put-call ratio

Macro factor sensitivity

Growth+11.1
Credit-0.9
Liquidity-5.5
Inflation+8.2
Commodities+3.5
Interest Rates-1.0

Valuation

Dividend yield0.00%
PEG Ratio-0.12
Price to sales400.52
P/E Ratio-0.12
Enterprise Value to Revenue279.68
Price to book1.00

Upcoming events

Next earnings dayApril 3, 2025
Next dividend day
Ex. dividend dayApril 29, 2025

News

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss

Cyclacel Pharmaceuticals, Inc. (CYCC) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $7.35 per share a year ago.

Zacks Investment Research (November 13, 2024)
Cyclacel To Test Higher Doses Of Fadraciclib In Solid Tumor Patients

Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) is adding two dose levels in a protocol amendment to test higher doses of oral fadraciclib before determining the recommended Phase 2 dose anticipated in 2H of 2022, citing the absence of dose-limiting toxicities. Fifteen patients with.

Benzinga (June 30, 2022)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free